Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 16, 2017
Patent Application Number
14443557
Date Filed
November 15, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides stable liquid formulations for a recombinant biopharmaceutical protein comprising a soluble form of the human p75 TNF receptor fused to an Fe domain of a human immunoglobulin protein (TNFR:Fc). Typically, biopharmaceutical proteins such as monoclonal antibodies (mAbs) and immunoglobulin fusion proteins (e.g., immunoadhesion proteins) are produced by recombinant DNA technology in mammalian cell expression systems. In order to guarantee the reproducible clinical performance of a biopharmaceutical product, manufacturers have to deliver a product of consistent and reproducible quality.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
